Basics XOMA Corporation XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics. IPO Date: July 1, 1986 Sector: Healthcare Industry: Biotech Market Cap: $420.77M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.12% Avg Daily Range (30 D): $0.90 | 2.41% Avg Daily Range (90 D): $0.74 | 2.36% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 391 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 35 Institutional Trades Total Inst.Trades: 383 Avg Inst. Trade: $1.67M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.73M Avg Closing Trade (30 D): $2.24M Avg Closing Trade (90 D): $1.56M Avg Closing Volume: 78.01K     News Oct 17, 2025 @ 3:45 PM XOMA Royalty and LAVA Therapeutics Announce Amendm... Source: Globe Newswire Oct 2, 2025 @ 8:43 PM XOMA Royalty Extends Tender Offer to Acquire LAVA ... Source: Globe Newswire Oct 2, 2025 @ 8:43 PM XOMA Royalty Extends Tender Offer to Acquire LAVA ... Source: Globe Newswire Sep 23, 2025 @ 11:52 PM Mural Oncology Announces Commencement of Mailing o... Source: Mural Oncology Sep 22, 2025 @ 11:30 AM XOMA Royalty Declares Quarterly Preferred Stock Di... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.1 $.06 $-.45 Diluted EPS $-1.14 $.06 $-.45 Revenue $ 42.91M $ 15.91M $ 8.71M Gross Profit $ $ $ Net Income / Loss $ -2.86M $ 2.37M $ -3.97M Operating Income / Loss $ -27.04M $ 5.93M $ -7.25M Cost of Revenue $ $ $ Net Cash Flow $ -47.37M $ -11.39M $ -40.4M PE Ratio     Splits Oct 18, 2016:   1:20 Aug 18, 2010:   1:15